MALAT1 and colorectal cancer: Previous studies have demonstrated the prognostic value of MALAT1 in human cancer, and patients with enhanced level of MALAT1 had a higher risk of poor outcome in gastric cancer, esophageal squamous cell carcinoma, colorectal cancer and osteosarcoma [28–31].